Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial

BMJ : British Medical Journal
S K RoyR Chowdhury

Abstract

To investigate the impact of zinc supplementation in children with cholera. Double blind, randomised, placebo controlled trial. Dhaka Hospital, Bangladesh. 179 children aged 3-14 years with watery diarrhoea and stool dark field examination positive for Vibrio cholerae and confirmed by stool culture. Children were randomised to receive 30 mg elemental zinc per day (n=90) or placebo (n=89) until recovery. All children received erythromycin suspension orally in a dose of 12.5 mg/kg every six hours for three days. Duration of diarrhoea and stool output. Results 82 children in each group completed the study. More patients in the zinc group than in the control group recovered by two days (49% v 32%, P=0.032) and by three days (81% v 68%, P=0.03). Zinc supplemented patients had 12% shorter duration of diarrhoea than control patients (64.1 v 72.8 h, P=0.028) and 11% less stool output (1.6 v 1.8 kg/day, P=0.039). Zinc supplementation significantly reduced the duration of diarrhoea and stool output in children with cholera. Children with cholera should be supplemented with zinc to reduce its duration and severity. Clinical trials NCT00226616.

Associated Clinical Trials

References

Jan 1, 1995·Transactions of the Royal Society of Tropical Medicine and Hygiene·W A KhanD Mahalanabis
Nov 15, 2000·Journal of Tropical Pediatrics·P DuttaS K Bhattacharya

❮ Previous
Next ❯

Citations

Dec 20, 2011·Current Infectious Disease Reports·Ana A WeilJason B Harris
Nov 26, 2011·Current Infectious Disease Reports·Richard R Watkins
Sep 17, 2009·Nature Reviews. Microbiology·Eric J NelsonAndrew Camilli
Mar 13, 2009·The New England Journal of Medicine·Eric D Mintz, Richard L Guerrant
Oct 2, 2008·Current Opinion in Clinical Nutrition and Metabolic Care·Angus G Scrimgeour, Henry C Lukaski
Jan 11, 2008·BMJ : British Medical Journal·Marzia Lazzerini
Jun 10, 2011·PLoS Neglected Tropical Diseases·Paul FarmerJonathan L Weigel
Nov 22, 2011·Emerging Infectious Diseases·J Glenn Morris
Oct 10, 2013·The American Journal of Tropical Medicine and Hygiene·Brendan R Jackson The Cholera Serosurvey Working Group
Nov 1, 2011·Clinical Medicine : Journal of the Royal College of Physicians of London·Paul Kelly
Feb 5, 2013·Future Microbiology·Lola V Stamm, Benjamin Mudrak
Jul 2, 2010·International Journal of Pediatrics·Archana B PatelHemant Kulkarni
Apr 20, 2012·Expert Review of Anti-infective Therapy·Daniel T LeungEdward T Ryan
Jul 9, 2013·Critical Care Clinics·Srinivas MurthyNiranjan Kissoon
Oct 13, 2009·European Journal of Pharmacology·Roberto Berni CananiAlfredo Guarino
Jul 4, 2012·Lancet·Jason B HarrisStephen B Calderwood
Sep 2, 2014·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Selma C LiberatoKim Mulholland
Nov 5, 2016·Human Vaccines & Immunotherapeutics·Sachin N DesaiDominique Legros
Jun 26, 2017·The Journal of Infection·Hannah G DaviesStephen P Luby
May 2, 2018·The American Journal of Tropical Medicine and Hygiene·Shahnawaz AhmedAbu Syed Golam Faruque
Dec 21, 2016·The Cochrane Database of Systematic Reviews·Marzia Lazzerini, Humphrey Wanzira
Jun 30, 2014·The Cochrane Database of Systematic Reviews·Anjana Gulani, Harshpal S Sachdev
Jun 6, 2017·Frontiers in Microbiology·Varunkumar BhattaramKumar Venkitanarayanan
Jul 14, 2018·Nature Reviews. Disease Primers·Craig Baker-AustinJaime Martinez-Urtaza
Apr 13, 2021·ACS Infectious Diseases·Denise ChacAna A Weil
Sep 1, 2018·Current Epidemiology Reports·William DavisEric D Mintz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.